CEA – CARCINO EMBRYONIC ANTIGEN

The carcinoembryonic antigen (CEA) test is a diagnostic tool that assesses the levels of CEA, a specific blood protein. Generally, individuals are born with elevated CEA levels that tend to decline as they age. However, certain types of cancer can lead to an increase in the production of this protein. Healthcare providers utilize the CEA test to provide valuable insights into cancer diagnosis, guide treatment strategies, and monitor the effectiveness of ongoing therapies. By tracking changes in CEA levels, medical professionals can make informed decisions about the course of treatment and assess the overall progress of the patient’s response to interventions. The CEA test thus plays a crucial role in personalized and targeted cancer care, helping healthcare teams tailor their approaches based on the individual dynamics of each patient’s condition.